Xencor (XNCR) Cash & Equivalents (2013 - 2026)

Xencor's (XNCR) quarterly Cash & Equivalents came in at $14.2 million in Q1 2026, down 64.28% year-on-year from $39.7 million in Q1 2025, and down 73.79% on a QoQ basis from $54.1 million in Q4 2025.

Xencor (XNCR) Cash & Equivalents (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Cash & Equivalents data on file, last reported at $14.2 million in Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 64.28% year-over-year to $14.2 million in Q1 2026; TTM through Mar 2026 was $14.2 million, a 64.28% decrease from a year earlier, with the FY2025 full-year figure at $54.1 million, up 32.29% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $14.2 million, down from $54.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for XNCR reached as high as $78.3 million in Q1 2022 and fell as low as $14.2 million in Q1 2026.
  • Historically, Cash & Equivalents has averaged $44.7 million across 5 years, with a median of $44.4 million in 2025.
  • Across the five-year window, Cash & Equivalents soared 44.44% in 2025 and slumped 64.28% in 2026, its largest moves.
  • Year by year, Cash & Equivalents stood at $53.9 million in 2022, then slipped by 0.28% to $53.8 million in 2023, then retreated by 24.01% to $40.9 million in 2024, then soared by 32.29% to $54.1 million in 2025, then slumped by 73.79% to $14.2 million in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $14.2 million in Q1 2026, $54.1 million in Q4 2025, and $28.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 82.45 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.83 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 440.94 Mn
10 Xencor 1.49 Bn 1.11 Bn - 14.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.17 Mn
Dec 31, 2025 54.07 Mn
Sep 30, 2025 28.29 Mn
Jun 30, 2025 44.44 Mn
Mar 31, 2025 39.68 Mn
Dec 31, 2024 40.88 Mn
Sep 30, 2024 29.03 Mn
Jun 30, 2024 30.77 Mn
Mar 31, 2024 31.03 Mn
Dec 31, 2023 53.79 Mn
Sep 30, 2023 52.73 Mn
Jun 30, 2023 34.71 Mn
Mar 31, 2023 72.39 Mn
Dec 31, 2022 53.94 Mn
Sep 30, 2022 52.65 Mn
Jun 30, 2022 49.41 Mn
Mar 31, 2022 78.27 Mn
Dec 31, 2021 143.48 Mn
Sep 30, 2021 41.20 Mn
Jun 30, 2021 115.84 Mn